Chaired by Robert Seder, VRC/NIAID

Balcony A, Natcher Conference Center

The increased awareness of the need to develop new vaccines, in some cases against pathogens that do not induce a high level of protective immunity in their hosts, has focused attention on the rational, efficient development of new vaccines for diseases such as HIV/AIDS, West Nile virus, SARS, and avian influenza.  NIH has major programs in this area of research, ranging from basic discovery science to translational work to clinical trials.  The speakers in this session will discuss new insights into the basic immunobiology of immune activation that are being used for vaccine design, Malaria Vaccine Unit vaccine strategies, the antigens, vectors, and immunization schemes being developed to improve human immune responses, and the strategies for the development of vaccines to emerging pathogens.

Program:

Rational Design of Vaccines for Infections Requiring Cellular Immunity
Robert Seder, NIAID

Enhancing Immune Responses to Blood-stage Malaria Vaccine
Carole Long, NIAID

Vaccine Approaches to Preventing Benign and Malignant Disease Caused by Human Papillomavirus Infection
Doug Lowy,NCI

Vaccines against SARS and Avian Influenza Viruses
Kanta Subbarao, NIAID